6550--FY25: VISN 8 Molecular Pathogen Detection

The Department of Veterans Affairs (VA) Regional Procurement Office East (RPOE), Network Contracting Office 8 (NCO 8) has issued a Special Notice announcing its intent to award a sole source contract for VISN 8 Molecular Pathogen Detection. The notice pertains to in-vitro diagnostic test panels and equipment for seven VA medical centers across Florida and Puerto Rico. The solicitation is specifically focused on molecular pathogen detection reagents and equipment lease using polymerase chain reaction (PCR) methodology. The contract will utilize the Biomerieux Biofire FilmArray Torch Multiplex PCR system or an equivalent technology. The procurement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC code 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets.

The purpose of this sole source procurement is to secure diagnostic testing capabilities for various medical panels including Gastrointestinal, Meningitis/Encephalitis, Joint Infection, Pneumonia, Blood Culture Identification, and Respiratory panels. Contractors interested in challenging the sole source approach must submit a capability statement to Paul Jarrett at paul.jarrett@va.gov by December 20, 2024, at 3:00 PM ET. The response must include company information, point of contact details, Federal Supply Schedule (FSS) status, socioeconomic categories, and relevant experience, limited to one page. The contract period of performance will span from December 31, 2024, through December 30, 2029, with four one-year option periods available. While no specific set-aside is indicated, contractors must demonstrate capability to meet the technical requirements and provide the necessary diagnostic testing equipment and reagents for VA medical facilities in the specified regions.